Referral: Veterinary medicinal products containing amoxicillin, amoxicillin Article 141(1)(i) procedures Under evaluation, 10/09/2026

Human medicines European public assessment report (EPAR): Xeljanz, tofacitinib, Date of authorisation: 22/03/2017, Revision: 38, Status: Authorised

Human medicines European public assessment report (EPAR): Zoledronic acid Mylan, zoledronic acid, Date of authorisation: 23/08/2012, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Tagrisso, osimertinib, Date of authorisation: 01/02/2016, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Moventig, naloxegol, Date of authorisation: 07/12/2014, Revision: 20, Status: Authorised

Fifth European Medicines Agency (EMA) - Vaccines Europe bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 26 October 2026, 14:00 (CET) to 26 October 2026, 16:00 (CET)

Product Management Service (PMS) public API beta release - Technical overview and live demo, Online, from 13 July 2026, 14:00 (CEST) to 13 July 2026, 15:30 (CEST)

Clinical investigation of medicinal products for treatment of migraine - Scientific guideline

Draft guideline on clinical investigation of medicinal products for the treatment of migraine and cluster headache - Revision 2

PSUSA/00000405/202601